%20(7).jpg)
%20(5).jpg)
.jpg)
Digital Archive
This story is part of our historical records. While preserved for reference, some details and facts may have evolved since its original publication 6 months ago.
Immuno Life Pvt Ltd launches “30 M’s Tulsi Nasya Inhaler” – A distinctive tulsi inhaler
The recently launched “Tulsi Nasya Inhaler” works in both preventive as well as corrective measures. August 3: The covid-19 pandemic was a bane for humanity, causing millions of people to lose their lives. Smell loss is among the very first signs of COVID-19. Due to olfactory dysfunction, there comes the need for effective respiratory products […]
S
Sangri Today Spotlight
BREAKING
PNN
4 years ago
Immuno Life Pvt Ltd launches “30 M’s Tulsi Nasya Inhaler” – A distinctive tulsi inhaler
The recently launched “Tulsi Nasya Inhaler” works in both preventive as well as corrective measures. August 3: The covid-19 pandemic was a bane for humanity, causing millions of people to lose their lives. Smell loss is among the very first signs of COVID-19. Due to olfactory dysfunction, there comes the need for effective respiratory products […]
Full Story: https://www.sangritoday.com/spotlight/immuno-life-pvt-ltd-launches-30-ms-tulsi-nasya-inhaler-a-distinctive-tulsi-inhaler
The recently launched “Tulsi Nasya Inhaler” works in both preventive as well as corrective measures.
August 3: The covid-19 pandemic was a bane for humanity, causing millions of people to lose their lives. Smell loss is among the very first signs of COVID-19.
Due to olfactory dysfunction, there comes the need for effective respiratory products like inhalers. IMMUNO LIFE PVT LTD, an Ayurvedic company that Manufactures, Exports, Supplies, and Trades quality Ayurvedic and Herbal products, launched its first distinctive product, “Tulsi Nasya Inhaler” that works in both preventive as well as corrective measures.
Discerning the public demand, IMMUNO LIFE has applied for the product’s patent.
history
This is an archived post. The information provided may be outdated.
rss_feed
Disclaimer:
Story published through syndicated feed.
